Genetic epilepsies as a cause of seizures in Neonates

Adam L Numis1, Marie-Coralie Cornet2, Hannah C Glass3

  • 1Department of Neurology and Weill Institute for Neuroscience, University of California San Francisco, San Francisco, CA. USA; Department of Pediatrics, University of California San Francisco, San Francisco, CA. USA.

Seminars in Perinatology
|September 20, 2025
PubMed

Insights

Genetic epilepsies in newborns require specific management. Advances in genetic testing enable precise diagnosis, guiding targeted treatments like channel blockers and vitamin therapies for better outcomes.

Area of Science:

  • Neonatal Neurology
  • Clinical Genetics
  • Epileptology

Background:

  • Neonatal seizures are often linked to acute brain injuries, but genetic epilepsies represent a significant subgroup requiring specialized care.
  • Understanding the genetic basis of neonatal epilepsies is crucial for accurate diagnosis and effective treatment strategies.

Purpose of the Study:

  • To review current knowledge on neonatal-period epilepsies.
  • To highlight the diagnostic and therapeutic implications of genetic epilepsies in newborns.
  • To emphasize the role of advanced genetic testing in precision medicine for these conditions.

Main Methods:

  • Comprehensive literature review summarizing current research on neonatal epilepsies.
  • Analysis of advances in genetic testing technologies, including exome and genome sequencing.
  • Examination of treatment strategies based on specific genetic etiologies.

Main Results:

  • Genetic epilepsies are categorized into channelopathies, synaptopathies, inborn errors of metabolism, and brain malformations.
  • Specific therapies, such as sodium channel blockers, vitamin therapies, and dietary interventions, show efficacy in certain genetic epilepsies.
  • Rapid genetic sequencing facilitates timely diagnosis and precision treatment in critically ill neonates.

Conclusions:

  • Early identification of genetic epilepsies in neonates is critical for optimizing current care.
  • Precise diagnosis guides prognosis and therapeutic decisions, improving seizure control.
  • Despite advances, poor developmental outcomes highlight the need for disease-modifying therapies.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.4K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
697
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.2K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.6K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
902